St Petersburg, FLNCT06253871Now EnrollingIRB Ready

HER2 Mutation-Related Tumors Clinical Trial in St Petersburg, FL

Access cutting-edge her2 mutation-related tumors treatment through this clinical trial at a research site in St Petersburg. Study-provided care at no cost to qualified participants.

Sponsored by Iambic Therapeutics, Inc

Quick Self-Assessment

See if you qualify for this St Petersburg location

Preparing your pre-screening questions…

Expert Care in St Petersburg

Access her2 mutation-related tumors specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related her2 mutation-related tumors treatment provided free

Apply for This St Petersburg Location

Check if you qualify for this her2 mutation-related tumors clinical trial in St Petersburg, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to St Petersburg

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit St Petersburg site if eligible
  4. 4Begin participation

About This HER2 Mutation-Related Tumors Study in St Petersburg

This is a Phase 1/1b open-label, multi-center dose escalation and dose optimization study designed to evaluate the safety and preliminary efficacy of IAM1363 in participants with advanced cancers that harbor HER2 alterations.

Sponsor: Iambic Therapeutics, Inc

Who Can Participate

Inclusion Criteria

Age ≥ 18 years
Have relapsed/refractory HER2-altered malignancy; for selected cohorts, prospective confirmation of HER2 alteration by central testing is required
Have progression of disease after the last systemic therapy, or be intolerant of last systemic therapy
Have radiographically measurable disease by RECIST v1.1 and/or RANO-BM
Eastern Cooperative Oncology Group (ECOG) performance score 0-1
Have adequate baseline hematologic, liver and renal function
Have left ventricular ejection fraction (LVEF) ≥ 50%
Able to swallow oral medication Key

Exclusion Criteria

Clinically significant cardiac disease
Infection with human immunodeficiency virus (HIV)-1 or HIV-2. Exception: Participants with well-controlled HIV (e.g., CD4 \>350/mm3 and undetectable viral load) are eligible
Current active liver disease including hepatitis A, hepatitis B , or hepatitis C
Refractory nausea and vomiting, malabsorption, external biliary shunt, or significant small bowel resection that would preclude adequate absorption
Uncontrolled diabetes
History of solid organ transplantation
History of Grade ≥2 CNS hemorrhage, or any CNS hemorrhage within 28 days before C1D1
Prior history of non-infectious interstitial lung disease (ILD). (Exceptions: participants with prior grade 1 ILD that has completely resolved are eligible)
Participants requiring immediate local therapy for brain metastases

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in St Petersburg?

Yes, this clinical trial (NCT06253871) has an active research site in St Petersburg, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

HER2 Mutation-Related Tumors Treatment Options in St Petersburg, FL

If you're searching for her2 mutation-related tumors treatment options in St Petersburg, FL, this clinical trial (NCT06253871) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our St Petersburg research site is actively enrolling participants for this clinical trial. You'll receive care from experienced her2 mutation-related tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all her2 mutation-related tumors clinical trials near you to find additional studies recruiting in your area.

More Breast Cancer Trials in St Petersburg, FL

See all breast cancer clinical trials recruiting in St Petersburg — not just this study.

Browse Breast Cancer Trials in St Petersburg →

Browse More Trials by Condition

Breast Cancer TrialsErectile Dysfunction TrialsAll Conditions →

Ready to Join in St Petersburg?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · St Petersburg, FL